Rodolphe J. Poussot - 23 Jul 2025 Form 3 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
SVP, Strategy & Corporate Dev
Signature
/s/ Louis Lalli, as an agent for Rodolphe Poussot
Issuer symbol
WST
Transactions as of
23 Jul 2025
Net transactions value
$0
Form type
3
Filing time
01 Aug 2025, 16:14:13 UTC
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Poussot Rodolphe Jean SVP, Strategy & Corporate Dev 530 HERMAN O. WEST DRIVE, EXTON /s/ Louis Lalli, as an agent for Rodolphe Poussot 01 Aug 2025 0002079538

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WST Common Stock 253 23 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding WST Rst. Stock Unit 23 Jul 2025 Common Stock 765 $0.000000 Direct F1
holding WST Rst. Stock Unit 23 Jul 2025 Common Stock 329 $0.000000 Direct F2
holding WST Stock Option (Right to Buy) 23 Jul 2025 Common Stock 1,577 $350.18 Direct F3
holding WST Stock Option (Right to Buy) 23 Jul 2025 Common Stock 760 $211.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in three equal installments beginning on February 20, 2025.
F2 This award vests in four equal installments beginning on February 18, 2026.
F3 This award vests in four equal installments beginning on February 20, 2025.